One should not use AOD-9604 if they: Are pregnant or breastfeeding Are a minor Have a current or recent history of cancer (particularly hormone-sensitive cancers) Have uncontrolled diabetes or significant insulin resistance Have active thyroid disease that is not well-managed Are taking medications that may interact with peptide therapy (discuss with your provider) Have a known hypersensitivity to peptide compounds Comprehensive labs including metabolic panel, fasting glucose, HbA1c, thyroid panel, lipid panel, and hormone levels should be run before starting any peptide therapy and monitored regularly throughout
The tirzepatide vs semaglutide side effects comparison shows tirzepatide generally has a comparable safety profile to other GLP-1 class medications
Vera-Cruz, A., Tanphaichitr, N., and Angel, J.B., Clin
Obesity disrupts the HPG axis and reproductive hormone balance and raises oxidative stress levels, resulting in reduced sperm concentration, motility, and viability, as well as increased numbers of abnormal sperm